[Antacid effect of a magnesium trisilicate-1-hyoscyamine combination preparation (Neoplex B)--clinical and function analytical studies].
D000863:Antacids / Q000627:therapeutic use; D001532:Atropa belladonna / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004381:Duodenal Ulcer / Q000188:drug therapy; D005745:Gastric Acidity Determination; D005756:Gastritis / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012822:Silicon Dioxide / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000188:drug therapy
D000863:Antacids; D012822:Silicon Dioxide; D008274:Magnesium
Antazider Effekt eines Magnesiumtrisilikat-1-HyoszyaminKombinationspräparates.